Autonomic drugs 0423FA Flashcards
nicotinic ACh receptor
ligand gated Na-K channels.
subtypes: Nn and Nm
muscarinic ACh receptor
GPCR acting through second messengers.
subtypes: M1-M5
Gq
activate phospholipase C, which (though PIP2) activates protein kinase C (DAG) and increases cytosolic Ca for contraction (IP3)
Gs
activates adenylyl cyclase to increase cAMP which activates protein kinase A to increase Ca in heart and MLCK of smooth mm.
Gi
INHIBITS adenylyl cyclase, opposite of Gs
alpha 1 [symp]
Gq:
increase vasc smooth muscle contraction. increase pupillary dilator muscle contraction (mydriasis).
increase intestinal and bladder sphincter muscle contraction.
alpha 2 [symp]
Gi:
decrease symp outflow.
decrease insulin release.
beta 1 [symp]
Gs:
increase HR, contractility.
increase lipolysis.
increase renin release.
beta 2 [symp]
Gs: vasodilation, bronchodilation. increase HR and contractility. increase lipolysis. increase insulin release. decrease uterine tone.
M1 [parasymp]
Gq: CNS, enteric nervous system.
M2 [parasymp]
Gi: decrease HR and contractility of atria.
M3 [parasymp]
Gq:
increase exocrine gland secretion (sweat, gastric acid).
increase gut peristalsis.
increase bladder contraction.
bronchoconstriction.
increase pupillary sphincter muscle contraction (miosis).
ciliary muscle contraction (accommodation).
D1 [dopamine]
Gs: relax renal vasc smooth muscle.
D2 [dopamine]
Gi: modulate transmitter release, esp. in brain.
H1 [histamine]
Gq: increase nasal and bronchial mucus prod. contraction of bronchioles. pruritus. pain.
H2 [histamine]
Gs: increase gastric acid secretion.
V1 [vasopressin]
Gq: increase vasc smooth muscle contraction.
V2 [vasopressin]
Gs: increase water perm and reabsorp in collecting tubules of kidneys.
hemicholinium
blocks reuptake of choline into presynaptic neuron. choline is necessary for ACh synthesis.
vesamicol
blocks transport of ACh into vesicles that are supposed to fuse with membrane and release ACh.
botulinum toxin
prevent ACh release at all cholinergic terminals
pathway from tyrosine to NE/epi
tyrosine (tyrosine hydroxylase) to DOPA (DOPA decarboxylase) to dopamine (dopamine beta-hydroxylase) to NE (PNMT) to epinephrine
metyrosine
inhibits tyrosine hydroxylase
reserpine
inhibits transport of dopamine into vesicles where NE is formed
guanethidine
inhibits NE (catecholamine) release at nerve endings
amphetamine
enhances catecholamine release. inhibits reuptake.
what three drugs inhibit catecholamine reuptake at nerve terminal?
- amphetamine
- cocaine
- TCA
what factors affect NE release from symp nerve ending?
- neg feedback by NE (on alpha2 auto receptor)
- ACh at M2 receptor downregulates
- AII upregulates
bethanechol
cholinomimetic. direct agonist.
for postop and neurogenic ileus; urinary retention.
activates bowel and bladder smooth mm.
resistant to AChE.
carbachol
cholinomimetic. direct agonist.
for glaucoma, pupillary contraction, relief of IOP.
pilocarpine
cholinomimetic. direct agonist.
potent stimulator of sweat, tears, saliva.
contracts ciliary muscle of eye (open angle) and pupillary sphincter (narrow angle).
resistant to AChE.
methacholine
cholinomimetic. direct agonist.
challenge test for dx of asthma.
stimulates muscarinic receptor in airway when inhaled.
neostigmine
cholinomimetic. indirect agonist (anticholinesterase).
for postop and neurogenic ileus; urinary retention.
myasthenia gravis. reverse NMJ block.
NO CNS PENETRATION.
pyridostigmine
cholinomimetic. indirect agonist (anticholinesterase).
for myasthenia gravis (long acting, increase strength).
NO CNS PENETRATION.
edrophonium
cholinomimetic. indirect agonist (anticholinesterase).
for dx of myasthenia gravis (extremely short acting)
physostigmine
cholinomimetic. indirect agonist (anticholinesterase).
for glaucoma - DOES CROSS BBB.
for atropine overdose.